Ozempic / GLP-1 Lawsuits Statistics in Wilmington
~71,000
City Population
~720,000
Metro Population (Wilmington-Newark)
2 years from discovery
DE SOL
Corporate home of Novo Nordisk Inc. & Eli Lilly
Strategic Significance
Courts in Wilmington, Delaware
New Castle County Superior Court
500 N King St, Wilmington, DE 19801
U.S. District Court, District of Delaware
844 N King St, Wilmington, DE 19801
Hospitals & Trauma Centers in Wilmington
ChristianaCare — Gastroenterology
4755 Ogletown-Stanton Rd, Newark, DE 19718
Nemours Children's Hospital Delaware
1600 Rockland Rd, Wilmington, DE 19803
Liability Considerations in Wilmington
Ozempic Litigation in Wilmington / Delaware
Wilmington holds unique strategic significance for GLP-1 litigation. Both Novo Nordisk Inc. and Eli Lilly maintain Delaware corporate registrations, giving Delaware courts unquestioned personal jurisdiction. New Castle County Superior Court has extensive experience with pharmaceutical mass tort coordination — demonstrated in the Zantac litigation where Delaware was one of the most active state court venues. Delaware state court filing is a viable alternative to MDL participation for GLP-1 claimants seeking state court advantages. Cases are also consolidated in MDL 3094 (E.D. Pennsylvania). Wilmington-area claimants and out-of-state plaintiffs should consult experienced counsel about Delaware filing strategy.